Diabetes Drug articles & resources on Made-in-China.com

U.S. Food and Drug Administration Will Investigate Possible Links

Feb 25, 2014

TUESDAY Feb. 11, 2014, 2014 -- The U.S. Food and Drug Administration announced Tuesday that it will investigate possible links between the diabetes drug saxagliptin and a heightened risk for heart failure among users. In a statement, the ...

Tags: FDA, Diabetes Drug, Heart Failure, NEJM

Tegra Medical Tegra Medical Announces The Appointment of Mr.J.Mark King as Its New CEO

Feb 11, 2014

Tegra Medical Tegra Medical announces the appointment of Mr.J.Mark King as its new Chief Executive Officer. BOSTON,MA,January 15,2014-Tegra Medical is very pleased to announce the appointment of Mr.J.Mark King as its new Chief Executive ...

Tags: Tegra, Tegra Medical, Health care

Here Are Some of The Latest Health and Medical News Developments

Jan 10, 2014

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Officials Confirm First North American Death From H5N1 Bird Flu The first death in North America from H5N1 bird flu has been ...

Tags: Health Highlights, Health

A Type of Diabetes Drug Lowers Cancer Risk in Women,While Another Type Increases Risk

Dec 27, 2013

A certain type of diabetes drug may lower cancer risk in women with type 2 diabetes by up to one-third, while another type may increase the risk, according to a new study. Cleveland Clinic researchers analyzed data from more than 25,600 ...

Tags: diabetes drug, lower cancer risk, women with type 2 diabetes

It Isn't Much More Weight Than Kids Who Only Make The Lifestyle Changes

Dec 26, 2013

Obese children who don't have type 2 diabetes but take the diabetes drug metformin while improving their diet and exercise habits seem to lose a bit of weight. But it isn't much more weight than kids who only make the lifestyle changes, ...

Tags: obese children, type 2 diabetes, diabetes drug, metformin, loss weight

Sanofi Has Released Results of a 24-Week Phase Iiib Clinical Trial

Dec 9, 2013

Sanofi has released results of a 24-week Phase IIIb clinical trial showing that Lyxumia (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered to patients either before breakfast or the ...

Tags: Diabetes Drug, Medicine

MannKind Has Resubmitted a New Drug Application to The FDA

Oct 16, 2013

US-based biopharmaceutical company MannKind has resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking marketing authorization for its AFREZZA inhalation powder, indicated to improve glycemic control ...

Tags: Insulin Application, biopharmaceutical company MannKind

Some Real Deals If You Use Cash or Credit Card Instead of Insurance

May 6, 2013

Many retailers offer discount prices on generics that may be cheaper than your co-pay. We asked our Secret Shoppers to price common generic drugs at more than 200 pharmacies around the U.S. and they found some real deals if you use cash or ...

Tags: Service, insurance

The Study of Profil Institute's Early Phase Clinical Services

Apr 15, 2013

Mercodia, a developer of immunoassays, has entered into a collaboration agreement with Profil Institute for Clinical Research. Under the alliance, Mercodia will offer its enzyme-linked immnosorbent assays (ELISA) as a component for Profil ...

Tags: Profil Institute, Mercodia, Clinical

Take Byetta or Januvia to Control Your Blood Sugar Levels Might Have a Risk

Mar 6, 2013

If you take Byetta or Januvia to control your blood sugar levels, you might have a small, but increased risk for a condition marked by stomach pain and nausea. Not only are the drugs more expensive and no more effective than our Best Buy ...

Tags: Byetta, Januvia, blood sugar levels, diabetes

Takeda Receives Response From FDA Regarding Its New Drug Applications

Dec 4, 2012

Takeda Pharmaceutical has received a complete response letter from the US Food and Drug Administration (FDA) regarding its new drug applications (NDAs) for alogliptin and the fixed-dose combination therapy alogliptin and pioglitazone. ...

Tags: FDA, alogliptin, clinical trial program

Boehringer Is Set to Launch Diabetes in India with Eli Lilly

Nov 27, 2012

Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name trajenta) 5mg film-coated tablets, for Type 2 diabetes in adults, in India. Linagliptin, which is approved in the US, the European Union, Japan and ...

Tags: Diabetes Drug, product of Boehringer, diabetes epidemic

GSK Pay $3bn for Promoting Antidepressants Paxil and Wellbutrin for Unapproved Uses

Jul 3, 2012

GlaxoSmithKline (GSK) will pay $3bn, which includes a $1bn criminal fine and forfeiture and $2bn to resolve civil claims, in fine and will plead guilty for promoting antidepressants Paxil and Wellbutrin for unapproved uses. The largest ...

Tags: antidepressant, criminal fine, civil claim, health care fraud

Diabetes Drug

Related Products